TCT 2022 Presentation Slides | SYMPLICITY HTN-3: Long-Term Outcomes
Image Modality: Illustration Table Figure
Description:
TCT 2022 Presentation Slides | SYMPLICITY HTN-3: Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-year Follow-up of the SYMPLICITY HTN-3 Trial
Date: September 18, 2022
Clinical Topics: Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Vascular Medicine, Pulmonary Hypertension, Hypertension
Keywords: Transcatheter Cardiovascular Therapeutics, TCT22Slides, Hypertension, Hypertension, Pulmonary, Catheters, Sympathectomy, Blood Pressure Monitoring, Ambulatory